Related Experiment Video
Updated: Jun 6, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Nucleic acid drugs: recent progress and future perspectives.
Xiaoyi Sun1, Sarra Setrerrahmane2, Chencheng Li1
1Jiangsu Province Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation, China Pharmaceutical University, Nanjing, 210009, China.
Nucleic acid drugs (NADs) offer efficient gene editing but face delivery challenges. Advances in chemical modification and delivery strategies are improving their stability, targeting, and clinical application for various diseases.
Area of Science:
- Biotechnology
- Pharmacology
- Molecular Biology
Background:
- Therapeutic agent development faces challenges with small molecules and biologics, particularly for 'undruggable' diseases.
- Nucleic acid drugs (NADs) represent a promising new generation of gene-editing modalities with high efficiency and rapid development potential.
Purpose of the Study:
- To review the development, classification, and delivery strategies of nucleic acid drugs (NADs).
- To highlight the clinical successes, limitations, and future potential of NADs in gene therapy.
Main Methods:
- Literature review of NADs development, chemical modification techniques, and various delivery approaches.
- Analysis of clinical trial data and approved therapeutic applications of NADs.
Main Results:
- Chemical modifications enhance NADs' physicochemical properties, but carriers are often needed for cellular uptake and intracellular targeting.
- Multiple delivery strategies have been developed to improve NADs' in vivo bioavailability and intracellular delivery.
- Several NADs have progressed to clinical trials and gained regulatory approval for therapeutic use.
Conclusions:
- NADs show significant promise as gene therapy candidates, overcoming limitations of traditional therapeutics.
- Continued advancements in delivery systems and chemical modifications are crucial for expanding NADs' clinical applications.
- NADs are evolving rapidly, offering new avenues for treating a wide range of diseases.
More Related Videos
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Nucleic Acids and Nucleotides
Deoxyribonucleic Acid (DNA)
DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and the organelles such as chloroplasts and mitochondria....
Viruses with RNA Genomes
Drug Discovery: Overview
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...